Ribozyme-mediated RNA degradation in nuclei suspension
- 25 June 1995
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 23 (12) , 2223-2228
- https://doi.org/10.1093/nar/23.12.2223
Abstract
Ribozymes containing 2′-fluoro- and 2′-amlno-modifled pyrimidine nucleosldes in combination with terminal phosphorothioate linkages were targeted against HTLV-I tax RNA. In oder to examine the activity of such chemically modified ribozymes in the nuclear environment, they were incubated with nuclei of a Tax-transformed mouse fibroblast cell line. Ribozyme cleavage of tax RNA was analyzed by the RNase protection assay. Comparison of the cleavage of tax RNA Isolated nuclei with that of tax RNA present in nuclei suspension revealed a 30 times more efficient cleavage of the latter one. Pre-treatment with protelnase K and SDS abolished the enhancement of the ribozyme-mediated RNA cleavage. Catalytically inactive ribozymes did not yield any cleavage products. These results demonstrate an augmenting effect of nuclear proteins on the ribozyme-mediated RNA cleavage.Keywords
This publication has 31 references indexed in Scilit:
- Functional NF-IL6/CCAAT enhancer-binding protein is required for tumor necrosis factor alpha-inducible expression of the granulocyte colony-stimulating factor (CSF), but not the granulocyte/macrophage CSF or interleukin 6 gene in human fibroblasts.The Journal of Experimental Medicine, 1995
- Inhibition of gene expression with ribozymesCellular and Molecular Neurobiology, 1994
- Interaction Between Tumour Necrosis Factor α Ribozyme and Cellular ProteinsJournal of Molecular Biology, 1994
- A Kinetic and Thermodynamic Framework for the Hammerhead Ribozyme ReactionBiochemistry, 1994
- Tethering Ribozymes to a Retroviral Packaging Signal for Destruction of Viral RNAScience, 1993
- Protein Enhancement of Hammerhead Ribozyme CatalysisScience, 1993
- Exploiting the chemical synthesis of RNATrends in Biochemical Sciences, 1992
- Ribozymes as Potential Anti-HIV-1 Therapeutic AgentsScience, 1990
- The tat Gene of Human T-Lymphotropic Virus Type 1 Induces Mesenchymal Tumors in Transgenic MiceScience, 1987
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976